| Down |
| 1. | Left main coronary artery occlusion |
| 2. | Cardiac marker that remains elevated for weeks |
| 3. | Preserves neurological function |
| 4. | Treatment for Vtach/Vfib |
| 5. | Clot buster |
| 8. | Leads II, III, and AVF |
| 9. | Nitroglycerine contraindicated with this drug |
| 10. | Door to baloon time in minutes |
| 12. | Myocardial infarction involving full thickness of the myocardium |
| 13. | Major cause of sudden cardiac death |
| 17. | Decreases myocardial oxygen demand (MVO2) |
| 18. | Preserves neurological function |
| 20. | Nonspecific enzyme that elevations within minutes of tissue damage |
| 21. | Should be performed and interpreted within 10 minutes of presentation with chest pain |
| 23. | Leads V1 and V2 |
| 25. | Over the counter antiplatelet |
| 26. | Cholesterol treatment |
| 28. | Door to baloon time in minutes |
| 29. | Leads V5-V1, leads 1 and AVL |